The first Novo Nordisk trade was made in Q1 2016.
Since then Jeremy Grantham bought shares five more times and sold shares on five occasions. The investor completely sold their stake between Q2 2019 and Q3 2019.
Avg closing price
Price range
Sold -1.47 Million shares
Q3 2019
Avg closing price
$50.57
Price range
$47.54
-
$53.43
Sold 37.7% shares (-887 Thousand shares)
Q2 2019
Avg closing price
$49.42
Price range
$46.79
-
$52.47
Increased shares by 17.6% (+352 Thousand shares)
Q1 2019
Avg closing price
$49.15
Price range
$46.36
-
$52.63
Increased shares by 1.7% (+34.2 Thousand shares)
Q4 2018
Avg closing price
$44.44
Price range
$41.54
-
$47.25
Increased shares by 44.4% (+605 Thousand shares)
Q3 2018
Avg closing price
$48.80
Price range
$46.76
-
$51.24
Increased shares by 3.7% (+49.1 Thousand shares)
Q2 2018